bioRxivGenomicsPreprint
Using somatic data to aid germline clinical variant interpretation in developmental disorders
Katrina A. AndrewsiD, Matthew D. C. NevilleiD, Inigo Martincorena, Raheleh RahbariiD, Helen Firth, Sarah LindsayiD, Marc D. TischkowitziD, Matthew E. HurlesiD
- Citations
- 1
Abstract
Accurate interpretation of rare germline variants remains a major challenge in developmental disorders (DD). Somatic mutation data represent a largely untapped source of evidence for germline variant classi-fication. Identical or nearby mutations that drive positive selection when present in somatic tissues can cause developmental disorders when present in the germline. We integrated somatic mutation data from the Catalogue Of Somatic Mutations In Cancer (COSMIC), and healthy tissues (sperm and buccal epithelium) with germline variant datasets from ClinVar and large studies of de novo mutations in DD patients. Across 970 dominant DD genes, 195 have evidence of somatic selection, with a majority demonstrating concordant mechanisms between germline and somatic contexts. We benchmark the ability of somatic data to discriminate pathogenic from benign germline missense variation across dominant DD genes, identifying 145 genes in which somatic data are informative. The strongest utility is in altered-function genes where germline and somatic mechanisms are concordant, for example the RASopathy genes. In these genes, codon-level aggregation of somatic missense counts yields predictive performance comparable to computational predictors or MAVE assays (AUC-ROC 0.895 for somatic data, versus 0.893 for REVEL). Combining somatic features with computational scores improves discrimination further. Using likelihood ratios, we map COSMIC missense codon count thresholds onto American College of Medical Genetics and Genomics/Association for Molecular Pathology (ACMG/AMP)-style evidence strengths, showing that somatic data can reach strong levels of evidence in germline variant interpretation in DD and enable reclassification of variants of uncertain significance. Together, these results establish somatic mutation data as a scalable and clinically actionable evidence source for germline variant interpretation in select DD genes. Graphical abstract(Generated using FigureLabs) O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=104 SRC="FIGDIR/small/732808v1_ufig1.gif" ALT="Figure 1"> View larger version (40K): org.highwire.dtl.DTLVardef@1d65659org.highwire.dtl.DTLVardef@beff70org.highwire.dtl.DTLVardef@174396dorg.highwire.dtl.DTLVardef@1662b08_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: whole-genome sequencing
- research focus: variant effect prediction
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Leveraging cancer mutation data to predict the pathogenicity of germline missense variants
Bushra Haque, David Cheerie, … Gregory Costain·medRxiv·Mar 11, 2024
- IMPROVE-DD: Integrating Multiple Phenotype Resources Optimises Variant Evaluation in genetically determined Developmental Disorders
Stuart Aitken, Helen V. Firth, … Colin A M Semple·Human Genetics and Genomics AdvancesPeer-reviewed·Nov 25, 2022
- Substantial role of rare inherited variation in individuals with developmental disorders
Kaitlin E. Samocha, V. Kartik Chundru, … Matthew E. Hurles·medRxiv·Aug 28, 2024
- A nationwide prospective randomized trial for diagnosing developmental disorders demonstrates genome sequencing outperforms standard of care.
Mathilde Geysens, Erika L. Souche, … Joris Robert Vermeesch·medRxiv·Oct 18, 2025
- Distinct mutational landscapes when comparing germline and somatic cancer variants in forty tumor suppressor genes.
Suhasini D. Lulla, Deborah Ritter, … Sharon E. Plon·bioRxiv·Feb 28, 2026
- Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation
Elizabeth J. Radford, Hong-Kee Tan, … Matthew E. Hurles·Nature CommunicationsPeer-reviewed·Dec 6, 2023